BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8421 related articles for article (PubMed ID: 11005552)

  • 1. Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?
    Shen P; Wanek LA; Morton DL
    Ann Surg Oncol; 2000 Sep; 7(8):554-9; discussion 560-1. PubMed ID: 11005552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
    Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
    Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence and survival after neck dissections in cutaneous head and neck melanoma.
    Andersen PS; Chakera AH; Thamsborg AK; Kølle SF; Schmidt G; Klyver H; Drzewiecki KT
    Dan Med J; 2014 Dec; 61(12):A4953. PubMed ID: 25441725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors after cervical lymph node dissection for cutaneous melanoma metastases.
    Grünhagen DJ; Eggermont AM; van Geel AN; Graveland WJ; deWilt JH
    Melanoma Res; 2005 Jun; 15(3):179-84. PubMed ID: 15917699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional control of head and neck melanoma with selective neck dissection.
    Geltzeiler M; Monroe M; Givi B; Vetto J; Andersen P; Gross N
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1014-8. PubMed ID: 25275362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
    Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of cervical lymph nodes in patients with cutaneous melanoma.
    Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
    Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of lymph nodes in head and neck melanoma: a retrospective study of 25 cases].
    Ricard AS; Majoufre-Lefebvre C; Delaunay M; Siberchicot F; Zwetyenga N
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):505-8. PubMed ID: 17900640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.
    Lee DY; Huynh KT; Teng A; Lau BJ; Vitug S; Lee JH; Stern SL; Foshag LJ; Faries MB
    Ann Surg Oncol; 2016 Mar; 23(3):1012-8. PubMed ID: 26586498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extent of the surgical intervention in regional metastases of melanomas of the head and neck].
    Vagner RI; Valdina EA; Anisimov VV
    Vestn Khir Im I I Grek; 1987 Jan; 138(1):43-6. PubMed ID: 3590534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
    Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiation after lymph node dissection for melanoma.
    Ridge JA
    Ann Surg Oncol; 2000 Sep; 7(8):550-1. PubMed ID: 11005550
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
    Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
    Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
    Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
    Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma.
    O'Brien CJ; Petersen-Schaefer K; Stevens GN; Bass PC; Tew P; Gebski VJ; Thompson JF; McCarthy WH
    Head Neck; 1997 Oct; 19(7):589-94. PubMed ID: 9323147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
    Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
    Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
    Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 422.